B8686

(+)-N-3-Benzyl Nirvanol

≥98% (HPLC), powder, CYP2C19 inhibitor

• Sinónimos: 5-ethyl-5-phenyl-3-(phenylmethyl)-2,4-imidazolidinedione, 5-ethyl-5-phenyl-3-(phenylmethyl)-hydantoin
• Fórmula empírica (notación de Hill): C₁₈H₁₈N₂O₂
• Número de CAS: 790676-40-3
• Peso molecular: 294.35
• MDL number: MFCD09840024
• UNSPSC Code: 12161501
• PubChem Substance ID: 329773138
• NACRES: NA.77

Propiedades

• product name: (+)-N-3-Benzyl Nirvanol, ≥98% (HPLC), powder
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: >20 mg/mL; H₂O: insoluble
• storage temp.: 2-8°C
• SMILES string: CC[C@]1(NC(=O)N(Cc2ccccc2)C1=O)c3ccccc3
• InChI: 1S/C18H18N2O2/c1-2-18(15-11-7-4-8-12-15)16(21)20(17(22)19-18)13-14-9-5-3-6-10-14/h3-12H,2,13H2,1H3,(H,19,22)/t18-/m0/s1
• InChI key: ZMZDHUHMXXALFX-SFHVURJKSA-N

Descripción

Application

(+)-N-3-Benzylnirvanol may be used as a cytochrome P450 2C19 (CYP2C19) inhibitor in a comparison study to treat cocktail and individual substrates for the screening for potent cytochrome P450 (CYP) inhibition. It may also be used in comparative studies to investigate its potential as CYP and non-CYP selective inhibitors of CYP2C19 in suspended human hepatocytes.

Biochem/physiol Actions

(+)-N-3-Benzyl-nirvanol is a potent selective CYP2C19 inhibitor. CYP2C19 has a high frequency of drug resistance; highly polymorphic.

(+)-N-3-Benzylnirvanol serves as an inhibitor of cytochrome P450 2B6 (CYP2B6).

Información de seguridad

• pictograms: GHS07,GHS09
• signalword: Warning
• hcodes: H302,H319,H400
• pcodes: P264 - P270 - P273 - P280 - P301 + P312 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Acute 1 - Eye Irrit. 2
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves